Lightnews — Scholar-powered news

Genes & Diseases Journal @genesndiseases.bsky.social · 1h

This latest review explores how expression quantitative trait loci are identified, analyzed, and tracked across different #Physiological stages and examines key data resources and their application in #Clinical #diseases. #medsky #ClinicalGenetics

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 4h

This study reveals cell types that influence #ImmuneCheckpointInhibitor response in #HepatocellularCarcinoma & identifies potential drug candidates using bulk & single-cell sequencing, offering a roadmap for novel #Immunotherapy strategies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 7h

You can now follow Genes & Diseases on YouTube.
www.youtube.com/@GenesNDisea...

Genes & Diseases Journal @genesndiseases.bsky.social · 7h

Genes & Diseases invites reviewers with expertise in:
Human genetics & genomics
Cancer biology
Neurological, cardiovascular, and metabolic disorders
Translational medicine and more
Contact us: [email protected]
#Genetics #PeerReview #GenesAndDiseases

Reposted by Genes & Diseases Journal

BioNews Central @bionewscentral.com · 16h

Scientists have developed a highly accurate #BloodTest to diagnose #ChronicFatigueSyndrome, also known as #MyalgicEncephalomyelitis (ME/CFS).
#MECFS #LongCOVID

New accurate blood test for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) unveiled – BioNews Central

Scientists have developed a highly accurate blood test to diagnose Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis (ME/CFS). ...

sbee.link

3 3

Reposted by Genes & Diseases Journal

Precision Oncology News @preconcnews.bsky.social · 15h

The company expects top-line results in 2026 from this group of the basket trial testing the drug plixorafenib as a next-generation monotherapy.

First Interim Analysis of Fore's BRAF Inhibitor Demonstrates Preliminary Efficacy in CNS Tumors

www.precisionmedicineonline.com

1

Reposted by Genes & Diseases Journal

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 10h

🤖 #ESMOAI25: Your not-to-miss sessions! Clinical trials for AI and AI for clinical trials, featuring discussions on applications in breast cancer, pathology and more!
⏰ Register by 22 October and benefit from advantageous fees. #HealthAI #esmomeetings

🔗 https://ow.ly/VoHA50X7yR3

1 1

Genes & Diseases Journal @genesndiseases.bsky.social · 16h

CRISPR/CasRx knockdown of Ctnnb1 and Smo inhibits Wnt/β-catenin & Ihh signaling, alleviating osteoarthritis (OA), and holds therapeutic promise for OA. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

1

Genes & Diseases Journal @genesndiseases.bsky.social · 23h

This study shows that #Mesenchymal-#Epithelial transition factor mutations enhance #Cancer immunity and may serve as #Biomarkers across cancer types to guide personalized #Immunotherapy strategies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

1 2

Genes & Diseases Journal @genesndiseases.bsky.social · 1d

A novel #METTL3 degrader, ZW27941, acts via the VHL-proteasomal pathway, showing promise in enhancing efficacy & overcoming resistance combined with existing treatments for #AcuteMyeloidLeukemia. @uflorida.bsky.social #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Reposted by Genes & Diseases Journal

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 2d

📣 #ESMOImmuno25: Stay ahead in the rapidly evolving field of immuno-oncology. Join the leading experts and pioneers that are driving progress in immuno-oncology.

⏰ Last chance to register and benefit from the best fees! Deadline 8 October 2025. #esmomeetings

🔗 https://ow.ly/ywTB50X7yOo

2 2

Reposted by Genes & Diseases Journal

The ASCO Post @ascopost.bsky.social · 2d

BART Trial Presented at the ASTRO Annual Meeting: Adjuvant RT after cystectomy + chemo in MIBC improves survival with no excess grade ≥3 toxicity

One of the first large randomized trials to show meaningful pelvic relapse reductions, says Vedang Murthy, MD

ascopost.com/news/septemb...

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer

Adjuvant radiation therapy after radical cystectomy and chemotherapy was found to be safe and efficacious for patients with locally advanced muscle-invasive bladder cancer, according to findings from ...

ascopost.com

1

Reposted by Genes & Diseases Journal

EACR - European Association for Cancer Research @helloeacr.bsky.social · 1d

Missed our recent free scientific webinar with QIAGEN?

Watch the replay of 'TCR Repertoires of Tumor-Infiltrating γδ T Cells Reveal PD-1-Modulated Reactivity': magazine.eacr.org/qiagen-webin...

1 1

Genes & Diseases Journal @genesndiseases.bsky.social · 1d

This study demonstrates the efficiency and safety of SIN-IL2RG-LV, paving the way for clinical trials in #XSCID treatment. #CellTherapy #MedicalResearch #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

This research provides a genomic and epigenomic map of ICE syndrome, shedding light on disease mechanisms and guiding the development of future targeted therapies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

This review highlights how #TCM compounds and monomers regulate #Ferroptosis, providing mechanistic insights into their therapeutic potential. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

www.sciencedirect.com

1

Reposted by Genes & Diseases Journal

The ASCO Post @ascopost.bsky.social · 3d

Phase II LUNAR Trial: PSMA-targeted radiopharmaceutical plus SBRT improved PFS in pts with oligometastatic prostate cancer (18 vs 7 mo), which helped to delay ADT by 24 months

Presented by Amar U. Kishan, MD, at the ASTRO Annual Meeting @astro-org.bsky.social

ascopost.com/news/septemb...

Prostate Cancer: Radiopharmaceutical Plus SBRT Delays Progression in Patients With Limited Metastatic Disease

In prostate cancer, radiopharmaceuticals typically target PSMA, delivering precise doses of radiation directly to tumors; these medicines are currently approved for later-stage prostate cancer. The LU...

ascopost.com

2 1

Reposted by Genes & Diseases Journal

IASLC @iaslc.bsky.social · 2d

Registration is open for the 2025 Hot Topic in Basic & Translational Science meeting!
See the outstanding faculty lineup and secure your seat today:
bit.ly/48epcNd

1

Reposted by Genes & Diseases Journal

EANO @eanoassociation.bsky.social · 2d

👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM

#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm

4 6

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

This top-downloaded article from April 2025 maps #ChronicMyeloidLeukemia-specific T cells at single-cell resolution & uncovers interactions between non-#ImmuneCells & T cell subsets in #BoneMarrow, offering novel #Immunotherapy strategies. #medsky OpenAccess: www.sciencedirect.com/science/arti...

www.sciencedirect.com

1 3

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

This review sheds light on the molecular mechanisms regulating endometrial carcinoma, highlights key gaps, and underscores the need for deeper mechanistic insights to inform future therapies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

www.sciencedirect.com

Reposted by Genes & Diseases Journal

Life Science Network @lifesciencenet.bsky.social · 5d

New AI system could accelerate clinical research.

#science #news #ai #clinicalresearch

www.lifescience.net/news/6581/ne...

New AI system could accelerate clinical research

By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.

www.lifescience.net

1 3

Reposted by Genes & Diseases Journal

International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 3d

#NETCancerDay is on November 10th. NETs are easily missed but early diagnosis is possible.
📢Please prepare to join the global NET community to speak in one global voice.
✅Check out INCA’ campaign toolkit how to get involved in NET Cancer Day: incalliance.org/ncd-2025/cam...
#LetsTalkAboutNETs

2 2

Reposted by Genes & Diseases Journal

EACR - European Association for Cancer Research @helloeacr.bsky.social · 3d

You might be interested to know about an upcoming EACR-sponsored meeting organised by the BACR, an affiliated National Society of the EACR.

BACR Annual Meeting 2025
📅 24 October
🌍 Leuven, Belgium

www.bacr.be/annual-meeti...

3 2

Reposted by Genes & Diseases Journal

International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 7d

Free CME Credit: Learn How to Diagnose and Manage Neuroendocrine Cancer in Primary Care.
• Online and self-paced
• Designed by international team of PCPs and NEN experts
• 7 languages
✅Start to #ThinkNENs today: incalliance.org/think-nens/
#LetsTalkAboutNETs

1